Nausea and diarrhea
Pro Research Analysisby 
Searched over 200M research papers
Nausea and Diarrhea: Insights from Recent Research
Nausea and Diarrhea in COVID-19 Patients
Prevalence and Persistence of Symptoms
Nausea and diarrhea are common gastrointestinal symptoms observed in COVID-19 patients. A systematic review and meta-analysis revealed that the global prevalence of prolonged nausea among COVID-19 survivors is approximately 3.23%, while prolonged diarrhea affects about 4.12% of survivors . Another meta-analysis found that the pooled prevalence of nausea or vomiting in COVID-19 patients is around 12%, and diarrhea is reported in 17% of cases . These symptoms can persist long after the acute phase of the infection, raising concerns about the long-term impact on survivors' quality of life .
Mechanisms and Severity
The mechanisms behind these symptoms in COVID-19 patients are multifaceted. The virus can infect gastrointestinal enterocytes, leading to the release of mediators that activate emetic pathways and cause nausea and vomiting . Additionally, the presence of viral RNA in fecal samples suggests gastrointestinal involvement, which may contribute to the severity of the disease . Patients with gastrointestinal symptoms, including diarrhea, are more likely to experience severe COVID-19, with an odds ratio of 1.71 for severe disease in those presenting with diarrhea .
Nausea and Diarrhea in Other Contexts
Outbreaks and Epidemics
Nausea and diarrhea are also prevalent in various outbreak scenarios. For instance, an outbreak of epidemic nausea, vomiting, and diarrhea in newborn infants demonstrated the high communicability of these symptoms, spreading from a maternity service to a child-caring institution and nearby homes . Such outbreaks necessitate careful epidemiological studies to differentiate between various diarrheal disorders and to implement appropriate control measures .
Acute Infectious Diarrhea
Acute infectious diarrhea, often accompanied by nausea and cramping, is a common clinical presentation. A case study of a 23-year-old man with acute onset watery diarrhea and associated nausea highlights the need for prompt evaluation and treatment to manage these symptoms effectively .
Treatment-Related Nausea and Diarrhea
Cancer Treatment
Patients undergoing treatment for early-onset colorectal cancer (EO-CRC) often experience higher incidences of nausea and vomiting compared to older patients, although the incidence of diarrhea remains similar . Factors such as peritoneal involvement, younger age, female gender, and specific chemotherapy agents like oxaliplatin may increase the risk of these symptoms .
Conclusion
Nausea and diarrhea are significant symptoms in various medical contexts, from infectious diseases like COVID-19 to treatment-related side effects in cancer patients. Understanding the prevalence, mechanisms, and management of these symptoms is crucial for improving patient care and outcomes. Further research is needed to explore the long-term impacts and develop targeted interventions for these debilitating symptoms.
Sources and full results
Most relevant research papers on this topic